#Japan #Tokyo #Gut Health #yogurt #Lactobacillus

Recent Findings on Gut Flora and Probiotics

A recent collaborative study conducted by Meiji Co., Ltd. and Tokai University Medical Center has shown promising results regarding the consumption of yogurt containing the probiotic Lactobacillus paragasseri OLL2716. The research indicates that continuous intake of this yogurt could potentially improve disturbances in gut flora associated with the use of acid-suppressive agents (ASAs) or low-dose aspirin (LDA).

Published in the international academic journal, Digestion, on June 23, 2026, the study's findings revealed significant differences between the gut flora of individuals taking ASAs or both ASAs and LDA compared to a control group that didn't take these medications. However, after regular consumption of the yogurt, no significant differences were found in gut flora among these groups, suggesting the yogurt could play a beneficial role in restoring gut balance.

Study Overview

The research involved participants categorized into three groups: those consuming only ASAs, those on both ASAs and LDA, and a control group not taking either medication. The gut flora of the participants was analyzed before and after the daily intake of yogurt containing the OLL2716 strain over a period of six weeks.

Key Findings

1. Changes in Gut Flora: The analysis showed that the gut flora in the ASAs and ASAs+LDA groups were significantly different from that of the control group before consuming the yogurt. Post-consumption, the yogurt led to an absence of significant differences in gut flora across all three groups.
2. Decreased Enterobacteriaceae in Stool: Specifically, in the ASAs group, the relative abundance of Enterobacteriaceae, a type of bacteria often associated with gut flora disturbances, significantly decreased following yogurt consumption.
3. Small Intestine Analysis: The study also highlighted a higher relative abundance of Enterobacteriaceae in the small intestine of participants who were on LDA, revealing the potential impact of these bacteria on intestinal health.

Implications of the Research

The results of this study suggest that yogurt containing OLL2716 may help improve gut flora disruptions characterized by high levels of Enterobacteriaceae. Given that these gram-negative bacteria are believed to contribute to mucosal damage in the small intestine induced by aspirin, the yogurt could serve as a preventive or mitigative measure against such effects.

Further research is needed to elucidate the mechanisms behind these benefits and to explore product development opportunities that incorporate this valuable probiotic strain into different food products designed for better gastrointestinal health.

Purpose of the Study

Low-dose aspirin is widely used for the prevention of cerebrovascular and cardiovascular diseases but has been known to cause mucosal damage in the stomach and small intestine. As a result, ASAs are often used alongside aspirin to protect the gastric mucosa. However, factors beyond gastric acid are believed to contribute to small intestinal mucosal damage, including disturbances in gut flora. The study aimed to investigate whether the intake of yogurt with the OLL2716 strain could address these disturbances and support gut health.

In conclusion, the promising results from this research highlight the potential of probiotics in everyday diet, specifically yogurt supplemented with beneficial bacterial strains like Lactobacillus paragasseri OLL2716. As studies continue to develop, we may see innovative methods emerge that leverage this strain to enhance gastrointestinal health in individuals taking medications like aspirin.